10[1]Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic troxide(As2O3) in the treatment of acute promyelocytic leukemia (APL):Ⅱ Clinical efficacy and pharmacokinetics in replased patients[J]. Blood, 1997;89(9):3354～3360
3Choy JC,Granville DJ,Hunt DW,et al.Endothelial cell apoptosis:biochemical characteristics and potential implications for atherosclerosis[J].Mol Cell Cardiol,2001,33(9):1673.
4Dou DQ,Zhang YW,Zhang L,et al.The inhibitory effect of ginsenosides on protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells[J].Planta Med,2002,67:19.
5Haverkate F.Levels of haemostatic fators,arteriosclarosis and cardiovascular disease[J].Vascul Pharmacol,2002,39:109.
6Rui WG,Li XY,Mao QL,et al.AngiotensinⅡ induced NF-κB activation in HUVEC via the p38 MAPK pathway[J].Peptides,2006,27:3267.
7Landon EJ,Inagami T.Beyond the G protein:the saga of the type 2 angiotensin Ⅱ receptor[J].Arterioscler Thromb Vasc Biol,2005,25:15.
